MELAIU, OMBRETTA
MELAIU, OMBRETTA
Dipartimento di Scienze cliniche e Medicina Traslazionale
A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people
2014-01-01 Garritano, S; De Santi, C; Silvestri, R; Melaiu, O; Cipollini, M; Barone, E; Lucchi, M; Barale, R; Mutti, L; Gemignani, F; Bonotti, A; Foddis, R; Cristaudo, A; Landi, S
A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma
2016-01-01 Figlioli, G; Elisei, R; Romei, C; Melaiu, O; Cipollini, M; Bambi, F; Chen, B; Kohler, A; Cristaudo, A; Hemminki, K; Gemignani, F; Forsti, A; Landi, S
A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays
2010-01-01 Caselli, C; Melaiu, O; Maltinti, M; Del Ry, S; Cabiati, M; Prescimone, T; Neglia, D; Giannessi, D
A Novel Panel of Serum Biomarkers for MPM Diagnosis
2017-01-01 Bonotti, A; Foddis, R; Landi, S; Melaiu, O; De Santi, C; Giusti, L; Donadio, E; Ciregia, F; Mazzoni, Mr; Lucacchini, A; Bovenzi, M; Comar, M; Pantani, E; Pistelli, A; Cristaudo, A
A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma
2012-01-01 Melaiu, O; Cristaudo, A; Melissari, E; Di Russo, M; Bonotti, A; Bruno, R; Foddis, R; Gemignani, F; Pellegrini, S; Landi, S
Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma
2016-01-01 Pelle, L; Cipollini, M; Tremmel, R; Romei, C; Figlioli, G; Gemignani, F; Melaiu, O; De Santi, C; Barone, E; Elisei, R; Seiser, E; Innocenti, F; Zanger, Um; Landi, S
Autophagy inhibition enhances T and NK immunogenicity in neuroblastoma
2024-03-10 DE MITRI, F; Theinert, T; Melaiu, O; Giansanti, M; Antonioli, M; Marabitti, V; Vulpis, E; Gatto, F; Caruso, S; Quintarelli, C; Fruci, D; Campello, S; Vacca, P; Caruana, I; Nazio, F
Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies
2024-01-01 Pomella, S; Melaiu, O; Cifaldi, L; Bei, R; Gargari, M; Campanella, V; Barillari, G
Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma
2020-11-01 Melaiu, O; Chierici, M; Lucarini, V; Jurman, G; Conti, L; De Vito, R; Boldrini, R; Cifaldi, L; Castellano, A; Furlanello, C; Barnaba, V; Locatelli, F; Fruci, D
Characterization of novel 3′untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide
2013-01-01 Melaiu, O; Facioni, Ms; Cabiati, M; Caruso, R; Giannessi, D; Landi, S; Gemignani, F; Del Ry, S
Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme
2023-01-01 Cerono, G; Melaiu, O; Chicco, D
Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma
2022-11-17 Lucarini, V; Melaiu, O; D'Amico, S; Pastorino, F; Tempora, P; Scarsella, M; Pezzullo, M; De Ninno, A; D'Oria, V; Cilli, M; Emionite, L; Infante, P; Di Marcotullio, L; De Ioris, Ma; Barillari, G; Alaggio, R; Businaro, L; Ponzoni, M; Locatelli, F; Fruci, D
Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma
2024-10-22 Tempora, P; D'Amico, S; Gragera, P; Damiani, V; Krol, K; Scaldaferri, V; Pandey, K; Chung, S; Lucarini, V; Giorda, E; Scarsella, M; Volpe, G; Pezzullo, M; De Stefanis, C; D'Oria, V; De Angelis, L; Giovannoni, R; De Ioris, Ma; Melaiu, O; Purcell, Aw; Locatelli, F; Fruci, D
Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival
2021-01-01 Melaiu, O; Macauda, A; Sainz, J; Calvetti, D; Facioni, Ms; Maccari, G; ter Horst, R; Netea, Mg; Li, Y; Grzasko, N; Moreno, V; Jurczyszyn, A; Jerez, A; Watek, M; Varkonyi, J; Garcia-Sanz, R; Kruszewski, M; Dudzinski, M; Kadar, K; Jacobsen, Seh; Mazur, G; Andersen, V; Rybicka, M; Zawirska, D; Razny, M; Zaucha, Jm; Ostrovsky, O; Iskierka-Jazdzewska, E; Reis, Rm; Stepien, A; Beider, K; Nagler, A; Druzd-Sitek, A; Marques, H; Martinez-Lopez, J; Lesueur, F; Avet-Loiseau, H; Vangsted, Aj; Krawczyk-Kulis, M; Butrym, A; Jamroziak, K; Dumontet, C; Vogel, U; Rymko, M; Pelosini, M; Subocz, E; Szombath, G; Sarasquete, Me; Silvestri, R; Morani, F; Landi, S; Campa, D; Canzian, F; Gemignani, F
Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (PLoS ONE (2017) 12:6 (e0180317) DOI: 10.1371/journal.pone.0085935)
2017-01-01 Melaiu, O; Stebbing, J; Lombardo, Y; Bracci, E; Uehara, N; Bonotti, A; Cristaudo, A; Foddis, R; Mutti, L; Barale, R; Gemignani, F; Giamas, G; Landi, S
Counter-regulation of regulatory T cells by autoreactive CD8 + T cells in rheumatoid arthritis
2019-01-01 Cammarata, I; Martire, C; Citro, A; Raimondo, D; Fruci, D; Melaiu, O; D'Oria, V; Carone, C; Peruzzi, G; Cerboni, C; Santoni, A; Sidney, J; Sette, A; Paroli, M; Caccavale, R; Milanetti, E; Riminucci, M; Timperi, E; Piconese, S; Manzo, A; Montecucco, C; Scrivo, R; Valesini, G; Cariani, E; Barnaba, V
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy
2024-01-01 Ielpo, S; Barberini, F; Dabbagh Moghaddam, F; Pesce, S; Cencioni, C; Spallotta, F; De Ninno, A; Businaro, L; Marcenaro, E; Bei, R; Cifaldi, L; Barillari, G; Melaiu, O
Dendritic cells: Behind the scenes of t-cell infiltration into the tumor microenvironment
2021-01-01 Lucarini, V; Melaiu, O; Tempora, P; D'Amico, S; Locatelli, F; Fruci, D
Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism
2017-01-01 De Santi, C; Melaiu, O; Bonotti, A; Cascione, L; Di Leva, G; Foddis, R; Cristaudo, A; Lucchi, M; Mora, M; Truini, A; Tironi, A; Murer, B; Boldorini, R; Cipollini, M; Gemignani, F; Gasparini, P; Mutti, L; Landi, S
DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma
2023-01-31 Pomella, S; Cassandri, M; Melaiu, O; Marampon, F; Gargari, M; Campanella, V; Rota, R; Barillari, G
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2014 | A common polymorphism within MSLN affects miR-611 binding site and soluble mesothelin levels in healthy people | Garritano, S; De Santi, C; Silvestri, R; Melaiu, O; Cipollini, M; Barone, E; Lucchi, M; Barale, R; Mutti, L; Gemignani, F; Bonotti, A; Foddis, R; Cristaudo, A; Landi, S | Articolo su rivista | |
| 1-gen-2016 | A comprehensive meta-analysis of case-control association studies to evaluate polymorphisms associated with the risk of differentiated thyroid carcinoma | Figlioli, G; Elisei, R; Romei, C; Melaiu, O; Cipollini, M; Bambi, F; Chen, B; Kohler, A; Cristaudo, A; Hemminki, K; Gemignani, F; Forsti, A; Landi, S | Articolo su rivista | |
| 1-gen-2010 | A methodological reappraisal of total and high molecular weight adiponectin determination in human peripheral circulation: comparison of four immunometric assays | Caselli, C; Melaiu, O; Maltinti, M; Del Ry, S; Cabiati, M; Prescimone, T; Neglia, D; Giannessi, D | Articolo su rivista | |
| 1-gen-2017 | A Novel Panel of Serum Biomarkers for MPM Diagnosis | Bonotti, A; Foddis, R; Landi, S; Melaiu, O; De Santi, C; Giusti, L; Donadio, E; Ciregia, F; Mazzoni, Mr; Lucacchini, A; Bovenzi, M; Comar, M; Pantani, E; Pistelli, A; Cristaudo, A | Articolo su rivista | |
| 1-gen-2012 | A review of transcriptome studies combined with data mining reveals novel potential markers of malignant pleural mesothelioma | Melaiu, O; Cristaudo, A; Melissari, E; Di Russo, M; Bonotti, A; Bruno, R; Foddis, R; Gemignani, F; Pellegrini, S; Landi, S | Articolo su rivista | |
| 1-gen-2016 | Association between CYP2E1 polymorphisms and risk of differentiated thyroid carcinoma | Pelle, L; Cipollini, M; Tremmel, R; Romei, C; Figlioli, G; Gemignani, F; Melaiu, O; De Santi, C; Barone, E; Elisei, R; Seiser, E; Innocenti, F; Zanger, Um; Landi, S | Articolo su rivista | |
| 10-mar-2024 | Autophagy inhibition enhances T and NK immunogenicity in neuroblastoma | DE MITRI, F; Theinert, T; Melaiu, O; Giansanti, M; Antonioli, M; Marabitti, V; Vulpis, E; Gatto, F; Caruso, S; Quintarelli, C; Fruci, D; Campello, S; Vacca, P; Caruana, I; Nazio, F | Intervento a convegno | |
| 1-gen-2024 | Biomarkers Identification in the Microenvironment of Oral Squamous Cell Carcinoma: A Systematic Review of Proteomic Studies | Pomella, S; Melaiu, O; Cifaldi, L; Bei, R; Gargari, M; Campanella, V; Barillari, G | Articolo su rivista | |
| 1-nov-2020 | Cellular and gene signatures of tumor-infiltrating dendritic cells and natural-killer cells predict prognosis of neuroblastoma | Melaiu, O; Chierici, M; Lucarini, V; Jurman, G; Conti, L; De Vito, R; Boldrini, R; Cifaldi, L; Castellano, A; Furlanello, C; Barnaba, V; Locatelli, F; Fruci, D | Articolo su rivista | |
| 1-gen-2013 | Characterization of novel 3′untranslated regions and related polymorphisms of the gene NPPC, encoding for the C-type natriuretic peptide | Melaiu, O; Facioni, Ms; Cabiati, M; Caruso, R; Giannessi, D; Landi, S; Gemignani, F; Del Ry, S | Articolo su rivista | |
| 1-gen-2023 | Clinical Feature Ranking Based on Ensemble Machine Learning Reveals Top Survival Factors for Glioblastoma Multiforme | Cerono, G; Melaiu, O; Chicco, D | Articolo su rivista | |
| 17-nov-2022 | Combined mitoxantrone and anti-TGFβ treatment with PD-1 blockade enhances antitumor immunity by remodelling the tumor immune landscape in neuroblastoma | Lucarini, V; Melaiu, O; D'Amico, S; Pastorino, F; Tempora, P; Scarsella, M; Pezzullo, M; De Ninno, A; D'Oria, V; Cilli, M; Emionite, L; Infante, P; Di Marcotullio, L; De Ioris, Ma; Barillari, G; Alaggio, R; Businaro, L; Ponzoni, M; Locatelli, F; Fruci, D | Articolo su rivista | |
| 22-ott-2024 | Combining ERAP1 silencing and entinostat therapy to overcome resistance to cancer immunotherapy in neuroblastoma | Tempora, P; D'Amico, S; Gragera, P; Damiani, V; Krol, K; Scaldaferri, V; Pandey, K; Chung, S; Lucarini, V; Giorda, E; Scarsella, M; Volpe, G; Pezzullo, M; De Stefanis, C; D'Oria, V; De Angelis, L; Giovannoni, R; De Ioris, Ma; Melaiu, O; Purcell, Aw; Locatelli, F; Fruci, D | Articolo su rivista | |
| 1-gen-2021 | Common gene variants within 3′-untranslated regions as modulators of multiple myeloma risk and survival | Melaiu, O; Macauda, A; Sainz, J; Calvetti, D; Facioni, Ms; Maccari, G; ter Horst, R; Netea, Mg; Li, Y; Grzasko, N; Moreno, V; Jurczyszyn, A; Jerez, A; Watek, M; Varkonyi, J; Garcia-Sanz, R; Kruszewski, M; Dudzinski, M; Kadar, K; Jacobsen, Seh; Mazur, G; Andersen, V; Rybicka, M; Zawirska, D; Razny, M; Zaucha, Jm; Ostrovsky, O; Iskierka-Jazdzewska, E; Reis, Rm; Stepien, A; Beider, K; Nagler, A; Druzd-Sitek, A; Marques, H; Martinez-Lopez, J; Lesueur, F; Avet-Loiseau, H; Vangsted, Aj; Krawczyk-Kulis, M; Butrym, A; Jamroziak, K; Dumontet, C; Vogel, U; Rymko, M; Pelosini, M; Subocz, E; Szombath, G; Sarasquete, Me; Silvestri, R; Morani, F; Landi, S; Campa, D; Canzian, F; Gemignani, F | Articolo su rivista | |
| 1-gen-2017 | Correction: MSLN gene silencing has an anti-malignant effect on cell lines overexpressing mesothelin deriving from malignant pleural mesothelioma (PLoS ONE (2017) 12:6 (e0180317) DOI: 10.1371/journal.pone.0085935) | Melaiu, O; Stebbing, J; Lombardo, Y; Bracci, E; Uehara, N; Bonotti, A; Cristaudo, A; Foddis, R; Mutti, L; Barale, R; Gemignani, F; Giamas, G; Landi, S | Articolo su rivista | |
| 1-gen-2019 | Counter-regulation of regulatory T cells by autoreactive CD8 + T cells in rheumatoid arthritis | Cammarata, I; Martire, C; Citro, A; Raimondo, D; Fruci, D; Melaiu, O; D'Oria, V; Carone, C; Peruzzi, G; Cerboni, C; Santoni, A; Sidney, J; Sette, A; Paroli, M; Caccavale, R; Milanetti, E; Riminucci, M; Timperi, E; Piconese, S; Manzo, A; Montecucco, C; Scrivo, R; Valesini, G; Cariani, E; Barnaba, V | Articolo su rivista | |
| 1-gen-2024 | Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy | Ielpo, S; Barberini, F; Dabbagh Moghaddam, F; Pesce, S; Cencioni, C; Spallotta, F; De Ninno, A; Businaro, L; Marcenaro, E; Bei, R; Cifaldi, L; Barillari, G; Melaiu, O | Articolo su rivista | |
| 1-gen-2021 | Dendritic cells: Behind the scenes of t-cell infiltration into the tumor microenvironment | Lucarini, V; Melaiu, O; Tempora, P; D'Amico, S; Locatelli, F; Fruci, D | Articolo su rivista | |
| 1-gen-2017 | Deregulation of miRNAs in malignant pleural mesothelioma is associated with prognosis and suggests an alteration of cell metabolism | De Santi, C; Melaiu, O; Bonotti, A; Cascione, L; Di Leva, G; Foddis, R; Cristaudo, A; Lucchi, M; Mora, M; Truini, A; Tironi, A; Murer, B; Boldorini, R; Cipollini, M; Gemignani, F; Gasparini, P; Mutti, L; Landi, S | Articolo su rivista | |
| 31-gen-2023 | DNA Damage Response Gene Signature as Potential Treatment Markers for Oral Squamous Cell Carcinoma | Pomella, S; Cassandri, M; Melaiu, O; Marampon, F; Gargari, M; Campanella, V; Rota, R; Barillari, G | Articolo su rivista |